The Trump Administration has shown it will stop at nothing to undermine access to health care for marginalized communities. Most recently, the Administration has proposed to undermine critical protections against sex discrimination in Section 1557 of the Affordable Care Act, the Health Care Rights Law. Instead of combating discrimination in accessing health care and insurance coverage, the Administration is looking for any opportunity to weaken the Health Care Rights Law’s protections, which have been life saving for many transgender and non-binary people.
We conducted a systematic literature review of all peer-reviewed articles published in English between 1991 and June 2017 that assess the effect of gender transition on transgender well-being. We identified 56 studies that consist of primary research on this topic, of which 52 (93%) found that gender transition improves the overall well-being of transgender people, while 4 (7%) report mixed or null findings. We found no studies concluding that gender transition causes overall harm. As an added resource, we separately include 17 additional studies that consist of literature reviews and practitioner guidelines.
Approximately 75 percent of transgender women showed an improved quality of life after surgery, a study out of Germany found.
Today, HRC’s Parents for Transgender Equality National Council, a group of the nation’s leading parent-advocates in the fight for transgender equality, met with members of Congress to discuss their families’ moving journeys and the urgent need for Congress to pass the Equality Act. The Equality Act is a comprehensive LGBTQ civil rights bill which is a priority for the U.S. House’s new pro-equality leadership and is expected to be re-introduced soon
WASHINGTON, Jan 2, 2019 /PRNewswire/ — Novel studies published in the Men’s Health Issue of AACC’s journal Clinical Chemistry suggest that hormone therapy for transgender people increases the risk of blood clots less than birth control pills and does not increase the risk of cardiovascular disease at all. These preliminary results could help more transgender individuals to access essential hormone therapy by increasing physician comfort with prescribing it.
The plaintiffs take issue with an Obama-era rule they say would force them to “perform and provide insurance coverage for gender transitions and abortions.”
To the Executive Committee and Board of Directors of WPATH,